Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07DWS
|
|||
| Former ID |
DNC010046
|
|||
| Drug Name |
1-(2-(2-fluorobenzyloxy)phenyl)piperazine
|
|||
| Synonyms |
CHEMBL575899; 1-(2-(2-fluorobenzyloxy)phenyl)piperazine; BDBM50299784
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H19FN2O
|
|||
| Canonical SMILES |
C1CN(CCN1)C2=CC=CC=C2OCC3=CC=CC=C3F
|
|||
| InChI |
1S/C17H19FN2O/c18-15-6-2-1-5-14(15)13-21-17-8-4-3-7-16(17)20-11-9-19-10-12-20/h1-8,19H,9-13H2
|
|||
| InChIKey |
XMQIWPUGABPALG-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1... Bioorg Med Chem Lett. 2009 Dec 1;19(23):6604-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.